Despite a robust HIV portfolio and growing oncology sales, Gilead struggles to diversify revenue streams significantly. Learn ...

The final sample comprised 1,472 people with HIV (25% women; mean age, 51.8). Most patients (83.1%) had undetectable HIV ...

HIV infections (human immunodeficiency virus infections) include the spectrum of infections caused by the virus HIV that range from asymptomatic seropositivity to acquired immunodeficiency ...

On her way home from the hospital in Nkhoma in rural Malawi, the headlight beam from Jacqueline’s motorbike falls on ...

Joseph Kibler was born with HIV and has been battling the virus his whole life, but when he and his wife, Carey Cox, began the discussion of starting a family, that was only one piece of their ...

Researchers assessed the safety and efficacy of first-line antiretroviral therapy with bictegravir plus emtricitabine and tenofovir alafenamide in Black patients with HIV.

Whereas the AIDS-related deaths of thousands of men who have sex with men (MSM) and intravenous drug users had mostly been ...

Seven BE-4 rocket engines have been installed on Blue Origin’s first New Glenn booster. (Blue Origin Photo) Is Boeing thinking about unloading some of its space projects? Is Jeff Bezos’ Blue ...

HIV Statistics Among MSM While calculation methods and research definitions vary, those used in a 2024 review suggest that among the general population, the definition of men who have sex with men ...

In a significant advancement for its New Shepard program, Blue Origin has successfully completed its 27th mission, NS-27, introducing the second human-rated vehicle designed to enhance flight ...

Blue Origin completed a launch and landing of an uncrewed flight test Wednesday morning for its next New Shepard spacecraft that will one day take humans on suborbital trips high above Earth.

Blue Origin’s New Shepard rocket ship rises from its Texas launch pad. (Blue Origin via YouTube) Jeff Bezos’ Blue Origin space venture successfully sent a brand-new New Shepard rocket ship on ...